Senseonics Holdings (SENS) EBITDA Margin (2015 - 2026)
Senseonics Holdings' (SENS) quarterly EBITDA Margin came in at 271.93% in Q1 2026, down 5637.0% year-on-year from 4.91% in Q1 2025, and down 85.26% on a QoQ basis from 146.78% in Q4 2025.
Senseonics Holdings (SENS) EBITDA Margin (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of EBITDA Margin data on file, last reported at 271.93% in Q1 2026.
- On a quarterly basis, EBITDA Margin fell 5637.0% year-over-year to 271.93% in Q1 2026; TTM through Mar 2026 was 212.95%, a 8305.0% increase from a year earlier, with the FY2025 full-year figure at 193.83%, up 13922.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 271.93%, down from 146.78% in the prior quarter.
- Over the last five years, EBITDA Margin for SENS reached as high as 146.78% in Q4 2025 and fell as low as 692.55% in Q1 2022.
- Historically, EBITDA Margin has averaged 347.84% across 5 years, with a median of 338.56% in 2022.
- On a YoY basis, EBITDA Margin climbed as much as 163106 bps in 2022 and fell as far as 50712 bps in 2022.
- Year by year, EBITDA Margin stood at 338.56% in 2022, then surged by 37 bps to 211.76% in 2023, then climbed by 19 bps to 172.0% in 2024, then grew by 15 bps to 146.78% in 2025, then slumped by 85 bps to 271.93% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 271.93% in Q1 2026, 146.78% in Q4 2025, and 242.14% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | -271.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -271.93% |
| Dec 31, 2025 | -146.78% |
| Sep 30, 2025 | -242.14% |
| Jun 30, 2025 | -215.42% |
| Mar 31, 2025 | -215.57% |
| Dec 31, 2024 | -172.00% |
| Sep 30, 2024 | -535.94% |
| Jun 30, 2024 | -400.68% |
| Mar 31, 2024 | -361.24% |
| Dec 31, 2023 | -211.76% |
| Sep 30, 2023 | -311.99% |
| Jun 30, 2023 | -481.53% |
| Mar 31, 2023 | -476.41% |
| Dec 31, 2022 | -338.56% |
| Sep 30, 2022 | -380.12% |
| Jun 30, 2022 | -458.70% |
| Mar 31, 2022 | -692.55% |
| Dec 31, 2021 | 168.56% |
| Sep 30, 2021 | -453.88% |
| Jun 30, 2021 | -483.13% |